The unifying theme of this application is the incidence of multiple chronic conditions (MCC) and its mechanisms and health outcomes. In the United States, about 62% of Medicare recipients ages 65 to 74 years have MCC (= 2 chronic conditions), and the frequency increases dramatically to 82% above age 85. Because adults with MCC are at increased risk of functional decline and are particularly vulnerable to poor care, MCC threatens both the public and financial health of the United States. MCC prevalence may be reduced by delaying the onset of single conditions and combinations of conditions through modification of risk factors or determinants of diseases. However, current preventive efforts have partly failed because they have focused on one disease at a time and too late in life. For this reason, there is a critical need to identify groups of individuals at risk earlier in life, an to develop interventions to prevent MCC and its adverse health outcomes. These priorities were outlined in the Multiple Chronic Conditions Strategic Framework of the US Department of Health and Human Services (DHHS) of 2010. The DHHS also developed a list of 20 conditions considered a public health priority for the nation. Although data are available about the prevalence of MCC in the United States and worldwide, the incidence of MCC and its epidemiologic mechanisms and health outcomes remain poorly understood. The Rochester Epidemiology Project (REP) is an ideal environment to study the incidence of MCC because it includes information for all ages from newborns to death, regardless of insurance status or health care setting (both inpatient and outpatient care), and encompasses the full spectrum of care, from primary to tertiary care. In this renewal application, we propose to study the mechanisms of development of incident MCC for specific physical and mental health conditions across all ages (Aim 1), and to identify short-term and long-term health outcomes of incident MCC dyads (Aim 2). This knowledge will inform earlier and more integrated interventions to prevent MCC and to improve its outcomes at the local community level and at the national level, as recommended by the DHHS and other federal agencies. Finally, we will develop an innovative approach to share REP data and our MCC findings to inform research and practice (Aim 3). Broad sharing of the comprehensive and longitudinal REP data both locally and to the wider scientific, clinical, and public health community will allow investigators and practitioners worldwide to rapidly explore patterns of diseases, procedures, drug prescriptions, MCC, and their associations at no cost. In summary, the studies proposed here are novel, can be efficiently conducted using the REP, and are urgently needed.

Public Health Relevance

We propose to study the mechanisms and the health outcomes of newly developed multiple chronic conditions using the records-linkage system of the unique Rochester Epidemiology Project, which has captured comprehensive information about the medical care delivered to local residents since the 1960s. Our ultimate goal is to provide evidence to guide the prevention of multiple chronic conditions, and to improve health outcomes for those already affected. The studies proposed here are novel, can be efficiently conducted using the Rochester Epidemiology Project, and are urgently needed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG034676-50A1
Application #
8960156
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Dutta, Chhanda
Project Start
2010-07-01
Project End
2020-05-31
Budget Start
2015-09-30
Budget End
2016-05-31
Support Year
50
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Allen, Alina M; Therneau, Terry M; Larson, Joseph J et al. (2018) Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. Hepatology 67:1726-1736
Carvalho, Diego Z; St Louis, Erik K; Knopman, David S et al. (2018) Association of Excessive Daytime Sleepiness With Longitudinal ?-Amyloid Accumulation in Elderly Persons Without Dementia. JAMA Neurol 75:672-680
Sheen, Youn Ho; Rolfes, Mary C; Wi, Chung-Il et al. (2018) Association of Asthma with Rheumatoid Arthritis: A Population-Based Case-Control Study. J Allergy Clin Immunol Pract 6:219-226
Sanders, Thomas L; Pareek, Ayoosh; Hewett, Timothy E et al. (2018) Incidence of First-Time Lateral Patellar Dislocation: A 21-Year Population-Based Study. Sports Health 10:146-151
Sharma, Ayush; Mukewar, Saurabh; Mara, Kristin C et al. (2018) Epidemiologic Factors, Clinical Presentation, Causes, and Outcomes of Liver Abscess: A 35-Year Olmsted County Study. Mayo Clin Proc Innov Qual Outcomes 2:16-25
Bower, James H; Grossardt, Brandon R; Rocca, Walter A et al. (2018) Prevalence of and indications for antipsychotic use in Parkinson's disease. Mov Disord 33:325-328
Wennberg, Alexandra M V; Hagen, Clinton E; Petersen, Ronald C et al. (2018) Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging. Exp Gerontol 106:67-73
Kaur, Harsheen; Sohn, Sunghwan; Wi, Chung-Il et al. (2018) Automated chart review utilizing natural language processing algorithm for asthma predictive index. BMC Pulm Med 18:34
Stricker, Nikki H; Lundt, Emily S; Edwards, Kelly K et al. (2018) Comparison of PC and iPad administrations of the Cogstate Brief Battery in the Mayo Clinic Study of Aging: assessing cross-modality equivalence of computerized neuropsychological tests. Clin Neuropsychol :1-25
Madhavan, Malini; Hu, Tiffany Y; Gersh, Bernard J et al. (2018) Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation. Mayo Clin Proc 93:145-154

Showing the most recent 10 out of 881 publications